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At a Glance Commentary
Scientific Knowledge on the Subject. Non-invasive mechanical ventilation (NIV) is becoming 
increasingly used to assist spontaneous breathing during acute hypoxic de novo respiratory failure 
(AHRF), even though its potential therapeutic effect in this setting is controversial. Reported data 
show that NIV is used in 15% of patients with acute respiratory distress syndrome (ARDS) 
irrespective of the severity of respiratory failure and it seems to be associated with higher mortality 
in the case of failure. Several predictors of NIV failure in AHRF have been investigated but were 
found to be insufficient to aid the timing of endotracheal intubation. Thus, there is a need for an 
early robust predictor of NIV failure to avoid intubation delay.
What This Study Adds To The Field. Our exploratory study shows that, in patients with moderate 
to severe AHRF who were candidates for a 24-hour NIV trial, the magnitude of inspiratory effort 
relief was an early and accurate predictor of NIV failure. Our study suggests that monitoring of 
esophageal pressure might assist clinicians in the timing of intubation for patients with AHRF 
undergoing a NIV trial.
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Abstract
Rationale
The role of inspiratory effort has still to be determined as a potential predictors of non-invasive 
mechanical ventilation (NIV) failure in acute hypoxic de novo respiratory failure (AHRF).
Objectives
We explore the hypothesis that inspiratory effort might be a major determinant of NIV failure in 
these patients.
Methods
Thirty consecutive patients with AHRF admitted to a single center and candidates for a 24-hour NIV 
trial were enrolled. Clinical features, tidal changes in esophageal (ΔPes) and dynamic transpulmonary 
pressure (ΔPL), expiratory tidal volume, and respiratory rate were recorded on admission and 2-4-
12-24 hours after NIV start, and were tested for correlation with outcomes.
Measurements and Main Results
ΔPes and ΔPes/ΔPL were significantly lower 2 hours after NIV start in patients who successfully 
completed the NIV trial (n=18) compared to those who needed endotracheal intubation (n=12) 
[median=11 (IQR=8–15) cmH2O vs 31.5 (30–36) cmH2O, p<0.0001] while other variables differed 
later. ΔPes was not related to other predictors of NIV failure at baseline. NIV-induced reduction in 
ΔPes of 10 cmH2O or more after 2 hours of treatment was strongly associated to avoidance of 
intubation, and represented the most accurate predictor of treatment success (OR=15, 95%CI 2.8-
110, p=0.001, AUC=0.97, 95%CI 0.91–1, p<0.0001).
Conclusions
The magnitude of inspiratory effort relief as assessed by ΔPes variation within the first 2 hours of NIV 
was an early and accurate predictor of NIV outcome at 24 hours.
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Introduction
The role of assisted spontaneous breathing (SB) in patients with acute hypoxic de novo respiratory 
failure (AHRF) is still controversial. When acute lung injury is mild, SB is desirable to preserve 
respiratory muscle function, improve the ventilation/perfusion ratio and regional ventilation (1), 
and reduce sedation and days of invasive mechanical ventilation (MV) (2). On the other hand, recent 
studies have suggested that SB might be a potential mechanism for lung damage if acute respiratory 
distress is severe (3). In recent years, non-invasive mechanical ventilation (NIV) has been 
increasingly used to assist SB in the intensive care setting, even though its potential therapeutic 
effect in AHRF is still debated. It has been reported that NIV is used in 15% of patients with acute 
respiratory distress syndrome (ARDS) irrespective of the severity of respiratory failure and it seems 
to be associated with higher mortality when PaO2/FiO2 is lower than 150 mmHg (4). Moreover, some 
studies have shown that NIV failure is associated with increased mortality in patients with AHRF 
(4,5); however, when NIV treatment is successful, it might considerably reduce the risk of death and 
length of ICU stay in this subset of patients (5).
Despite the fact that several potential factors associated with NIV failure have been investigated in 
hypoxic patients, there are no robust predictors that might alert the intensivist to the need for 
endotracheal intubation (ETI) within the very first hours of ventilation (6). Although the mechanisms 
behind the association between NIV failure and poorer survival remain unclear, a potential role for 
SB might be hypothesized. When SB is preserved during AHRF, the intensity of inspiratory effort may 
follow a critical increase in respiratory drive thus producing uncontrolled swings in transpulmonary 
pressure (PL) that would increase the risk of injury to the dependent lung and predispose the patient 
to the onset of self-inflicted lung injury (SILI) (6). The underlying mechanisms of SILI are 
heterogeneous and include the pendelluft phenomenon, increased transvascular pressure gradient 
aggravating alveolar damage, excessive diaphragmatic loading with impaired systemic oxygen 
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delivery, and muscle injury (3,7–9).
In this study, we explore the hypothesis that, in patients with moderate or severe AHRF undergoing 
a NIV trial, the excessive spontaneous effort of the patients, measured with esophageal pressure 
swings (ΔPes), may be a major determinant of NIV failure at 24 hours.
Methods
Study population
This prospective observational cohort study was carried out in a single eight-bed Respiratory 
Intensive Care Unit (RICU) at the University Hospital of Modena (I) following approval from the 
Ethics Committee “Area Vasta Emilia Nord” (registered protocol number 4485/C.E., document 
266/16). After testing our study hypothesis in 4 patients (pilot data not included in the analysis) 
during the period October 2016 to December 2018, the study has been registered retrospectively 
on ClinicalTrial.gov (ID NCT03826797). Thirty consecutive patients were then enrolled in between 
February and October 2019. Written informed consent to participate in the study and to analyze 
and divulgate clinical data was obtained from all patients admitted.
Inclusion criteria were age > 18 years and the presence of AHRF with PaO2/FiO2 ratio < 200 mmHg 
despite high-flow nasal oxygen with flow set at 60 L/min, and a candidate to receive a NIV trial 
according to the attending RICU staff, whose decision was taken upon clinical conditions blinded to 
the purpose of the study. Patients were excluded in the case of a previously established diagnosis 
of chronic obstructive pulmonary disease; diagnosed pulmonary embolism; neuromuscular disease; 
cardiogenic acute pulmonary edema; interstitial lung disease; chest wall deformities; the need for 
immediate endotracheal intubation (ETI) as represented by any of the following: cardiopulmonary 
arrest; respiratory arrest; loss of consciousness with respiratory pauses; psychomotor agitation 
requiring sedation; pH less than 7.20; neurological deterioration or massive secretions; 
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hemodynamic instability or major electrocardiographic abnormalities; pregnancy; intolerance to 
NIV; hypercapnic respiratory failure of any etiology (PaCO2 > 45 mmHg); home long-term oxygen 
therapy; denied informed consent.
General measures
Demographics and relevant comorbidities were assessed on admission. Clinical severity as assessed 
by the Kelly Scale, the Acute Physiology and Chronic Health Evaluation II (APACHE II) score, the 
Simplified Acute Physiology Score (SAPS II), the Subsequent Organ Failure Assessment (SOFA) score 
and the Heart rate, Acidosis, Consciousness, Oxygenation and Respiratory rate (HACOR) score were 
assessed and recorded on admission and after 2, 4, 12, and 24 hours. Arterial blood gases (PaO2-
PaCO2), pH, PaO2/FiO2 ratio, respiratory rate (RR), and blood lactate values were recorded before 
NIV start and 2, 4, 12, and 24 hours later. A chest X-ray was taken on admission and 24 hours after 
NIV start.
Physiological measurements
A multifunctional nasogastric tube with a dedicated pressure transducer (NutriVentTM, SIDAM, 
Mirandola, Italy) was placed before starting NIV. The nasogastric tube was connected to a dedicated 
monitoring system (OptiVentTM, SIDAM, Mirandola, Italy) to record swings in esophageal (Pes) and 
dynamic transpulmonary (PL) pressures. In order to avoid using absolute values for Pes and PL, we 
always refer to ΔPes and ΔPL from the end-expiratory level, respectively (10). Appropriate catheter 
position was confirmed by visualization of cardiac artifacts on Pes traces and radiopaque markers on 
chest X-rays, and validation of esophageal pressure measurements was obtained through dynamic 
occlusion tests (11,12). ΔPes was calculated as the negative deflection of Pes from the onset of 
inspiratory effort. ΔPL was as the tidal change in transpulmonary pressure, calculated as airway 
pressure (Paw) minus Pes (10). 
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ΔPes, ΔPL, and ΔPes/ΔPL ratios were assessed on admission and 2, 4, 12, and 24 hours after NIV start. 
Initial measurements were performed at each pre-specified time point while the patient was 
breathing spontaneously through the ventilator circuit. Data were sampled at 100 Hz and processed 
on a dedicated data acquisition system (OptiVentTM, SIDAM, Mirandola, Italy) (12). Data sampling 
was numerically stored and downloaded via USB stick at each time of assessment. Offline breath-
by-breath analysis was then performed for each measurement then averaged by a specific software 
(Flux View Respiratory Mechanics Monitor (NBMED- Medical Graphics, Milano, Italy). For all the 
measurements the beginning of the inspiratory phase was identified at the instant of Pes initial decay 
while the end of inspiration considered at the point of Pes that elapsed 25% of time from its 
maximum deflection to return to baseline.  
Respiratory flow was measured by an external heated Fleisch No. 2 pneumotachograph (Fleisch, 
Lausanne, Switzerland) inserted between the patient’s oronasal facemask (BluestarTM, KOO Medical 
Equipment, Shanghai, PRC) and a connector with a side port for mechanical measurement. 
Expiratory tidal volume (Vte) was obtained by numerical integration of the flow signal. Vte was then 
adjusted to the predicted body weight (PBW) to derive Vte/kg of PBW. Vte/kg of PBW was assessed 
on admission and 2, 4, 12 and 24 hours after NIV start. Minute ventilation (VE) was calculated as the 
product of Vte and RR and assessed on admission and 2, 4, 12 and 24 hours after NIV start. Vte/ΔPL 
was further measured at each pre-defined time point.
Leaks from the oronasal facemask were computed using dedicated ventilator-integrated software 
(GE Healthcare Engstrom CarestationTM, GE Healthcare, Finland) based on the equation: leaks 
(L/min) = (inspiratory Vt – expiratory Vt) x RR.
All measurements were performed during a stable spontaneous breathing pattern of 5 minutes and 
results were averaged for each assessment step.
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NIV treatment
After NutriventTM placement, NIV was started and set by a respiratory physician with expertise in 
Respiratory Intensive Care. Patients were connected via a conventional circuit with an appropriately 
sized oronasal facemask equipped with a dedicated output for probes (BluestarTM, KOO Medical 
Equipment, Shanghai, PRC) to a high-performance ventilator (GE Healthcare Engstrom 
CarestationTM, GE Healthcare, Finland) in pressure support pre-set mode. Heat and moisture 
exchanger (HME) (HYGROBAC, DAR, Mirandola, Italy) was placed to the ventilator circuit's Y-piece. 
Positive end expiratory pressure (PEEP) was initially set at 6 cmH2O, and subsequently fine-tuned 
(4–8 cmH2O) in order to target a SatO2 > 92% with a delivered FiO2 less than 70%. Pressure support 
(PS) was set at 10 cmH2O, and then progressively modified, according to tidal volume (Vte/kg of 
PBW), in order to target a Vte/kg of PBW lower than 9.5 ml/kg of PBW and a RR lower than 30 
breaths/min. The oronasal facemask was finely adjusted to target a leak flow lower than 20 L/min. 
The inspiratory trigger was set at 3 L/min and respiratory cycling was set at 25% of the inspiratory 
peak flow. Great care was taken by the nurses in charge of NIV, and who were blinded to the 
protocol, to avoid any possible air leaks. The inspiratory fraction of oxygen delivered (FiO2) was 
increased to target a transcutaneous oxyhemoglobin saturation of 88–94%. Setting was adjusted by 
the attending physician blinded to the study purpose and based on blood gases and/or continuous 
oxymetry assessment. Patients receiving NIV treatment were not sedated. The decision as to 
whether to proceed to ETI at 24 hours after NIV start was taken according to best clinical practice 
by the attending RICU staff, blinded to the results of the physiological assessment acquired through 
the OptiventTM monitor only at each pre-defined time point. NIV failure was defined by the onset of 
the need for ETI or by death. Criteria for ETI included: (a) PaO2/FiO2 ratio unchanged or worsened 
or below 150 mmHg, (b) the need to protect airways due to neurological deterioration or massive 
secretions, (c) hemodynamic instability or major electrocardiographic abnormalities, (d) unchanged 
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or worsened dyspnea and persistence of respiratory distress (RR > 35 bpm, gasping for air, 
psychomotor agitation requiring sedation, abdominal paradox).
Outcome measures
The influence of ΔPes on NIV failure or success at 24 hours was pre-specified as a primary outcome. 
The impact of ΔPL, ΔPes/ΔPL ratio, PaO2/FiO2 ratio, RR, Vte/kg of PBW, Vte/ΔPL, VE and the HACOR 
score on NIV outcome at 24 hours and the correlation between ΔPes and radiographic changes on 
chest X-ray within the first 24 hours after NIV start were assessed as secondary outcomes. 
Radiographic changes on chest X-ray within the first 24 hours after admission were assessed by a 
radiologist with expertise in chest X-ray and blinded to the purpose of the study. Changes were 
classified as follows: relevant worsening, worsening, mild worsening, unmodified, relevant 
improvement, improvement, mild improvement.
Statistical analysis
The statistical package GraphPad Prism 8.0 (GraphPad Software, Inc., La Jolla, CA, USA) was used for 
statistical analysis. Due to the exploratory nature of the study, no sample size calculation was 
performed. Descriptive statistics was used to characterize the study population as a whole and 
according to primary outcome. The nonparametric Mann–Whitney and Student t test were used for 
the comparison of continuous variables. Comparison between dichotomous variables was 
performed by the χ2 test or Fisher's exact test, where appropriate. The time course of ΔPes, ΔPL, 
ΔPes/ΔPL ratio, PaO2/FiO2 ratio, Vte/kg of PBW, Vte/ΔPL, RR, VE and HACOR score according to NIV 
outcome within the first 24 hours of treatment was assessed through ANOVA analysis. Then a post-
hoc Bonferroni-Dunn’s multiple test was used to perform the pairwise comparison of means for 
each analyzed variable at the prespecified time points. The correlation between baseline values of 
ΔPes and PaO2/FiO2, Vte, RR, HACOR score, Vte/ΔPL and the chest X-ray radiographic categories was 
assessed through Pearson’s correlation coefficient. The impact of ΔPes change within 2 hours after 
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NIV start and baseline value of Vte/ΔPL on NIV outcome was assessed through a logistic regression 
model. A receiver operating characteristic (ROC) analysis was then performed to identify the best 
predictive cut-off for ΔPes change within 2 hours after NIV start and for baseline Vte/ΔPL. The 
association between the best cut-off value of ΔPes change after 2 hours of NIV and baseline Vte/ΔPL, 
Vte > 9.5 ml/kg of PBW, RR > 30 bpm, PaO2/FiO2 ratio < 150 mmHg and HACOR score > 5 within 2 
hours after NIV start on NIV failure at 24 hours was then tested through univariate logistic regression 
analysis. ROC analysis was used to assess the accuracy in predicting NIV failure at 24 hours for all 
the analyzed variables at pre-specified cut offs. Then, at 30 days, survival analysis was performed 
through a log-rank test for ΔPes change within 2 hours after NIV start. A p-value less than 0.05 was 
considered to be statistically significant.
Results
Patient characteristics
Over the study period, 30 out of 86 consecutive patients admitted for AHRF to the RICU of the 
University Hospital of Modena (Italy) and who were candidates to receive a NIV trial were enrolled 
in this study. Of these, 12 patients (40%) experienced NIV failure within 24 hours after NIV start. 
Those patients for which the need for ETI was defined at 24 hours as the “alert” criterion of our 
internal guideline, were thereafter intubated by the RICU staff.  Of those who were successful in the 
24-hour trial (60%), none were further intubated during their RICU stay. The flow chart for patients 
in this study is shown in Figure 1.
The general features and clinical characteristics of the whole population at baseline and according 
to NIV outcome at 24 hours are presented in Table 1. None of the features assessed were 
significantly different between the two groups of patients (NIV failure vs NIV success) at baseline. In 
particular, the overall population presented an average value of PaO2/FiO2 of 125 (interquartile 
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range [IQR] 101–170) mmHg, which did not differ significantly according to NIV outcome at 24 hours 
(100 [118–141] mmHg and 111 [132–173]) mmHg, respectively, p=0.5). All patients with ARDS 
(n=15) presented pulmonary ARDS. In 10 patients, the etiology was identified as infectious (bacterial 
n=4, fungal n=2, viral n=4) while for 5 patients, no etiological diagnosis was made. Patients with 
pneumonia had unilateral lung consolidation and 9 of them presented a bacterial infectious cause 
(Streptococcus pneumoniae n=4, intracellular pathogens n=4, Hemophilus influenzae n=1). The 
presence of pneumonia and ARDS was equally distributed between the two groups (42% vs 44% 
p>0.9, 58% vs 44% p=0.7, respectively).
Physiological measurements and NIV outcome
Table 2 shows the physiological dynamic respiratory mechanics for the whole population at baseline 
and in the NIV outcome subgroups at baseline and after 2 hours of NIV. At baseline, the median 
value of ΔPes was 34 (26–40) cmH2O. Of note, none of the physiological features analyzed were 
significantly different at baseline between the two groups. After 2 hours of NIV, the median value 
of ΔPes was significantly lower for those patients who were successful in the 24-hour NIV trial 
compared to patients who failed (11 [8–15] cmH2O vs 31.5 [30–36] cmH2O, p<0.0001). Moreover, 
these latter patients presented a significantly increased value of ΔPL once NIV had started compared 
to patients who experienced NIV success at 24 hours (39.5 [37.5–42-3] cmH2O vs 30.5 [28–43.5] 
cmH2O, p=0.04). 
Figure 2, panel A shows ΔPes changes from baseline within the first 2 hours of NIV for the whole 
population and according to NIV outcome at 24 hours. ΔPes decreased significantly after 2 hours of 
NIV for the whole population and for those patients who were successful in the NIV trial, whereas 
it did not change for patients who experienced NIV failure. Moreover, only these latter patients 
presented a significant increase in ΔPL after 2 hours of NIV (Figure 2, panel B).
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Waveform analysis of ΔPL and ΔPes swings 2 hours after NIV start is displayed in Figure 3, for a patient 
who failed the 24-hour NIV trial (panels A and C) and for a patient who succeeded (panels B and D). 
The time course of the physiological and clinical variables (ΔPes, ΔPL, ΔPes/ΔPL, RR, PaO2/FiO2 ratio, 
HACOR score, Vte/kg of PBW, Vte/ΔPL, and VE) in the two categories of patients according to NIV 
outcome showed a significant improvement over time in patients who were successful in the NIV 
trial. Moreover, only ΔPes significantly decreased earlier (2 hours after NIV start) in those patients 
who were successful in the NIV trial compared to those who failed (p<0.0001, Figure E1A, 
supplementary material). The ratio between ΔPes and ΔPL was significantly different 2 hours after 
NIV start between the two groups (p<0.0001, Figure E1C, supplementary material), while ΔPL 
(p=0.04, Figure E1B, supplementary material ), Vte/kg of PBW, VE, Vte/ΔPL (p=0.01, p=0.01, and 
p=0.001, Figure E2, panel A, B, C, respectively, supplementary material), RR, PaO2/FiO2, HACOR 
score (p=0.02, p<0.0001, and p=0.03, Figure E3, panel A, B, C, respectively, supplementary material) 
were all significantly different more than 2 hours after NIV start.
Significant inverse correlation was found between baseline ΔPes and Vte/ΔPL (r=-077, p<0.0001, 
Figure E4 supplementary material). No significant correlation was found between baseline ΔPes and 
PaO2/FiO2 ratio (r=–0.01, p=0.9, Figure E5, panel A supplementary material), RR (r=0.23, p=0.2, 
Figure E5, panel B supplementary material), HACOR score (r=0.05, p=0.8, Figure E5, panel C 
supplementary material), and Vte/kg of PBW (r=–0.05, p=0.8, Figure E5, panel D supplementary 
material). 
Radiological changes and inspiratory effort
The correlation analysis performed for radiographic changes showed that patients with a greater 
reduction in ΔPes 2 hours after NIV start experienced more consistent improvements on chest X-ray 
at 24 hours, whereas patients with a limited reduction of ΔPes were those who showed a 
deterioration on chest X-ray (Figure E6, supplementary material).
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Inspiratory effort and clinical outcome
In the logistic regression model, ΔPes changes within the first 2 hours of NIV showed a significant 
association with NIV failure at 24 hours (odds ratio [OR]=1.7, 95%CI 1.2–3, p=0.01) while baseline 
Vte/ΔPL was not significantly associated with NIV outcome (p=.03). From ROC analysis, ΔPes changes 
< 10 cmH2O gave the most accurate cut-off value for prediction of NIV failure (sensitivity 0.91 95%CI 
0.65–1, specificity 0.83 95%CI 0.61–0.94, likelihood ratio=5.5, positive predictive value=0.79, 95%CI 
0.52–0.92, negative predictive value=0.94 95%CI 0.72–1, Table E1, supplementary material);  
Vte/ΔPL < 0.33 ml/Kg/cmH2O showed the best cut-off value for prediction of NIV failure (sensitivity 
0.67 95%CI 0.40–0.86, specificity 0.5 95%CI 0.29–0.71, likelihood ratio=1.3, positive predictive 
value=0.47, 95%CI 0.26–0.7, negative predictive value=0.7 95%CI 0.42–87, Table E2, supplementary 
material. When univariate logistic regression was applied to the pre-specified potential predictors 
of NIV failure, ΔPes changes < 10 cmH2O showed the highest association with NIV failure at 24 hours 
(OR=15 95%CI 2.8–110, p=0.001). Among the other predictors tested, Vte > 9.5 ml/kg of PBW and 
HACOR > 5 after 2 hours of NIV were significantly associated with NIV failure at 24 h (OR=7.9 95%CI 
1.5–72, p=0.02 and OR=6.3 95%CI 0.9–49, p=0.046, respectively) while RR > 30 bpm, PaO2/FiO2 ratio 
< 150 mmHg and Vte/ΔPL < 0.33 ml/Kg/cmH2O, although strongly associated, did not reach 
statistical significance (Table 3). From ROC analysis, ΔPes changes < 10 cmH2O within the first 2 
hours after NIV start showed higher accuracy in predicting NIV failure (AUC=0.97 95%CI 0.91–1, 
p<0.0001) (Figure 4) than baseline Vte > 9.5 ml/kg of PBW, HACOR score > 5, RR > 30 bpm, PaO2/FiO2 
ratio < 150 mmHg and Vte/ΔPL < 0.33 ml/Kg/cmH2O (AUC=0.88 95%CI 0.76–0.99, p=0.0005, 
AUC=0.85 95%CI 0.71–0.99, p=0.00, AUC=0.83 95%CI 0.67–0.98, p=0.003, AUC=0.74 95%CI 0.56–
0.92, p=0.03, AUC= 0.58 95%CI 0.37-0.8, p=0.44, respectively).
Kaplan–Meier curves showed a significant increase in 30-day mortality among patients with ΔPes 
reduction < 10 cmH2O within the first 2 hours after NIV start compared to patients with a more 
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consistent early improvement (HR=4.5 95%CI 1.01–17.9, p=0.048, Figure E7 supplementary 
material).
Discussion
In this exploratory study, patients with moderate to severe AHRF undergoing a NIV trial presented 
a median baseline value for ΔPes of 34 cmH2O that was significantly reduced within the first 2 hours 
of ventilation in patients who were successful in the NIV trial, while those patients failing NIV did 
not have a significantly reduced ΔPes. This study therefore shows that a significant ΔPes reduction 
within the first 2 hours of NIV start was an early and accurate predictor of NIV outcome and was 
significantly correlated with radiographic changes after 1 day of NIV. Moreover, the magnitude of 
inspiratory effort at baseline did not show a significant correlation with the severity of respiratory 
failure, tidal volume, RR, and HACOR score on admission.
Physiological measurements and NIV outcome
Early prediction of NIV failure in AHRF
The application of NIV in treating patients with AHRF is a controversial issue and it is currently used 
in clinical practice irrespective of the severity of PaO2/FiO2. Despite the initial promising results on 
the effectiveness of NIV in patients with hypoxic respiratory failure (13,14), more recent studies 
focusing on patients with AHRF and excluding underlying chronic respiratory diseases or cardiogenic 
pulmonary edema warn of the increased mortality rates once ETI is delayed (5,15,16). Despite the 
fact that failure rates can exceed 60% in patients with more severe AHRF, successful application of 
NIV is independently associated with survival and shorter length of ICU stay (5). Giving these 
assumptions, it seems of critical interest to identify early predictors of NIV failure in order to avoid 
deleterious intubation delay in this subset of patients.
Previous studies have shown that several factors (i.e. higher severity score on admission, older age, 
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ARDS or pneumonia as the etiology for acute respiratory failure, or a lack of improvement in blood 
gas exchange within 1 hour of treatment) are associated with NIV failure in patients with AHRF, 
although these were insufficient to influence ETI timing (17). In our study, all of these factors were 
not different in patients who failed the 24-hour NIV compared to patients who were successful in 
the trial. In a recent single-center study, Duan and coworkers developed and validated the HACOR 
score for prediction of NIV failure in patients with AHRF, showing that patients with a HACOR score 
greater than 5 after the first hour of NIV were at greater risk for NIV failure and, if switched to 
invasive mechanical ventilation (MV) within the first 12 hours, presented reduced in-hospital 
mortality (18). In our study, the HACOR score was significantly associated with increased NIV failure 
but not as early as ΔPes. Moreover, both groups of patients presented a HACOR score greater than 
5 after the first 2 hours of NIV. Two recent studies have demonstrated that moderate-to-severe 
hypoxemia significantly affects NIV outcome in patients with ARDS-induced AHRF (19,20). Our study 
presented a carefully selected population of patients with moderate to severe AHRF, whose average 
PaO2/FiO2 was 132 mmHg and in whom significant differences between those who were successful 
in the NIV trial compared to those who were subjected to ETI did not become evident until 12 hours 
after the start of NIV. Of interest, the inspiratory effort at baseline as expressed by ΔPes did not show 
a significant correlation with the severity of respiratory failure. These findings are in line with data 
reported in a recent physiological study by Grieco et al. where ΔPe was unrelated to oxygenation 
impairment during helmet NIV and high flow oxygen treatment (21). Our data further underline the 
inability of PaO2/FiO2 ratio alone to identify patients with harmful respiratory drive.
In a recent trial, Carteaux and coworkers showed that a Vte value greater than 9.5 mL/kg was 
independently associated with NIV failure in patients with AHRF (22) suggesting a role of high Vte 
as a potential predictor of NIV failure in this setting (19). The results from our study are in line with 
their reported data although significant differences in Vte between patients who failed the NIV 
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treatment and those who were successful became evident 12 hours after NIV start. Moreover, the 
magnitude of inspiratory effort was not correlated with average Vte at baseline. Considering these 
data, the inability to apply protective ventilation should be considered a critical mechanism of NIV 
failure in this subset of patients.
The main result from our study was that a change in ΔPes less than 10 cmH2O within the first 2 hours 
after NIV start was an early and accurate predictor of NIV failure at 24 hours when compared to 
other variables, such as PaO2/FiO2, Vte, HACOR, and RR. From a clinical point of view, these data 
might suggest that, in patients with moderate to severe AHRF, the effectiveness of a NIV trial should 
be related to the reduction in the patient’s inspiratory effort, quantifiable through esophageal 
manometry. The consequences of this reduction translate into a subsequent significant reduction 
of Vte, a decrease in RR, and an improvement in PaO2/FiO2 with a few hours latency. Moreover, the 
correlation analysis showed that ΔPes on admission was not associated with the baseline value of 
other predictors of NIV failure. 
Radiological changes and inspiratory effort
Inspiratory effort and self-inflicted lung injury during NIV
Our results showed a significant correlation between ΔPes changes within the first 2 hours of NIV 
and radiographic progression at 24 hours. Despite being less accurate than a computed tomography 
scan, chest X-ray showed good sensitivity in detecting lung alteration in patients with ARDS (23) and 
might be considered reliable in the evaluation of the extent and distribution of lung opacities, once 
a diagnosis has already been made (24).
The results of our study support the hypothesis that inspiratory effort might be a potential 
mechanism of lung damage enhancement if acute respiratory distress is severe. Although data from 
animal models indicate ΔPL as a major determinant of SILI, experimental studies conducted on 
normal trained subjects during exhausting endurance exercise demonstrated that potentially 
Page 20 of 83
For Review Only
16
injurious values of ΔPL (up to 52 cmH2O) did not translate into lung mechanical changes (25,26). To 
understand this, we have to consider that, in normal fluid-like lung, the inspiratory swing in pleural 
pressure produced by inspiratory effort is homogeneously distributed across the pleural surface. In 
contrast, in injured solid-like lung, the inspiratory pleural swing is not uniformly dissipated, resulting 
in a more negative deflection in the dependent lung zones with tidal over-recruitment and local 
overstretch (6). More recently, two trials investigating the role of assisted SB in mechanically 
ventilated patients showed that SB was not associated with poorer outcome when compared to 
controlled MV (27,28), but they lacked assessment of the inspiratory effort. Our results might 
suggest that a major determinant in generating lung stress lies in the dynamic component of the 
inspiratory effort rather than in the absolute value of the pressure generated. Interestingly, within 
the first 2 hours of NIV, ΔPes/ΔPL was different in those who were successful in the NIV trial 
compared to those who failed it. This ratio might express to what extent dynamic ΔPL is affected by 
the patient’s respiratory drive and might introduce a new insight in the understanding of SILI. In 
particular, for the same value of ΔPL, patients who presented higher values of ΔPes experienced a 
higher NIV failure rate. This mechanism alongside a Vt of more than 6 ml, high breathing frequency 
and elevated mechanical power should be considered critical for SILI. These results highlight the 
potential role of the pendelluft phenomenon and negative pressure alveolar edema in determining 
SILI. Recently, in a rat model of acute lung injury, Henzler and coworkers showed that ΔPL was more 
important than inspiratory effort in generating ventilatory associated lung injury during partial 
ventilatory support (29). These results are apparently contradictory to those reported in our study, 
but some issue might have influenced the conclusions. First, the experimental PEEP was set at 5 
cmH2O which, in a murine model, is comparable to higher levels in larger animals, producing a sort 
of recruitment favoring a fluid-like behavior of the lung and reducing the harmful role of SB (25). 
Second, the animals ventilated with a lower level of support presented hypercapnic acidosis that 
Page 21 of 83
For Review Only
17
might have mitigated the ventilatory-associated lung injury. Furthermore, in our study we have 
assessed the Vte/ΔPL as a surrogate of lung compliance in order to explore the concept of baby lung 
during NIV. Data show an inverse linear correlation between Vte/ΔPL and inspiratory effort (Figure 
E4, supplementary material). Moreover, the time course of this index resulted different between 
those who succeeded the 24 hours NIV trial as compared to those who failed (Figure E2, panel C, 
supplementary material). Thus, this might justify the discrepancies in the behavior of Vte and 
inspiratory effort. Although not significantly associated with NIV failure this index deserves further 
investigations in larger physiological trials. 
Limitations of the study
Our study has several limitations. First, the number of patients might have underpowered the 
results obtained. In particular, the value of ΔPes changes < 10 cmH2O should be confirmed in larger 
trials. Second, our study population was highly selected influencing the generalization of our results. 
In particular, none of the patients who were successful in the 24-hour trial required further 
intubation thus indicating that patients were enrolled very early in the course of the disease. Third, 
we did not carry out any assessment of inflammatory biomarkers. The determination of cytokine 
levels might clarify the role of vigorous inspiratory effort in exaggerating lung injury. Moreover, as 
patients were studied during spontaneous breathing, what we measured was dynamic PL, thus the 
influence of the inspiratory and expiratory resistances on the measured pressures should be 
considered. Furthermore, we did not perform gastric pressure assessment, so ΔPes values may have 
been overestimated in the case of expiratory muscle recruitment. Finally, despite the fact that our 
study identifies ΔPes changes as the major and early physiological predictor of NIV failure, the 
evaluation of a composite parameter that takes into account the various components of the 
respiratory drive (including minute ventilation, respiratory rate, inspiratory flow rate and P0.1) as a 
bundle, might be of relevant clinical importance and should be assessed in further multicenter trials. 
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At this time, we believe that this technique produces highly reliable data if managed in centers with 
expertise in esophageal manometry. Notwithstanding this, an increase in its use should raise the 
level of confidence in daily clinical practice.
Conclusion
Even with the limitations described, our study highlights new concepts which can be summarized as 
follows: 1) patients with severe AHRF undergoing NIV may achieve harmful dynamic transpulmonary 
pressure levels, 2) the magnitude of inspiratory effort during NIV is the earliest and most accurate 
parameter that predicts failure, 3) the amount of inspiratory effort is not correlated with 
oxygenation, therefore PaO2/FiO2 ratio cannot be used as a surrogate of ΔPes, 4) the significant 
correlation between ΔPes changes within the first 2 hours of NIV and radiographic progression at 24 
hours suggest that SILI might be a potential mechanism of lung damage in these patients.
In the hypothesis of SILI as a critical factor affecting NIV failure in patients with AHRF, we found that 
the magnitude of inspiratory effort as assessed by ΔPes variation within the first 2 hours of NIV 
treatment is an early and accurate predictor of outcome at 24 hours. The clinical implications of our 
study suggest that monitoring esophageal pressure might help clinicians in the making decision 
process (airway intubation) for patients with AHRF undergoing a NIV trial. Due to the exploratory 
nature of this study, findings should be confirmed in multicenter clinical trials.
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Figure legends
Fig. 1. Flow chart for patients in this study.
Fig. 2. (A) ΔPes changes from baseline within the first 2 hours of NIV for the whole population and 
according to NIV outcome at 24 hours. (B) ΔPL changes from baseline within the first 2 hours of NIV 
for the whole population and according to NIV outcome at 24 hours.
Fig. 3. Graphical representation of ΔPL and ΔPes waveform swings after 2 hours of NIV for a patient 
who failed the NIV trial at 24 hours (panels A and C) and for a patient who was successful (panels B 
and D). The beginning of the inspiratory phase was identified at the time of Pes initial decay, while 
the end of inspiration was considered at the point of Pes that elapsed 25% of time from its maximum 
deflection to return to baseline.  
Fig. 4. Receiver operating characteristic (ROC) analysis. ΔPes changes < 10 cmH2O within the first 2 
hours of NIV showed a high accuracy in predicting NIV failure (AUC=0.97, p<0.0001).
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Tables
Table 1. Baseline features of the study population presented as a whole or as NIV outcome at 24 
hours
Feature Overall NIV failure NIV success p
Number of patients 30 12 18
Age, years (IQR) 71 (66–81) 69 (62–80) 71 (68–81) 0.7
Male, n (%) 20 (67) 8 (67) 12 (67) >0.9
BMI, kg/m2 (IQR) 23 (19–27) 22.5 (18–26) 24 (21–27) 0.3
Charlson index, score 
(IQR)
4 (3–5.5) 4 (3–5) 4.5 (3–6) 0.6
Pneumonia, n (%) 13 (23) 5 (42) 8 (44) >0.9
ARDS, n (%) 15 (50) 7 (58) 8 (44) 0.7
Kelly scale, score 
(IQR)
1 (1–1) 1 (1–1) 1 (1–1) 0.4
APACHE II, score 
(IQR)
27 (21–38) 24.5 (19–45) 28 (25–37) 0.8
SAPS II, score (IQR) 36 (26–41) 36 (31–38) 36 (25–44) 0.6
SOFA, score (IQR) 6 (4–8.8) 5.5 (3–8) 6.5 (4–9) 0.6
PaO2/FiO2, mmHg 
(IQR)
125 (101–170) 118 (100–141) 133 (111–144) 0.5
pH, value (IQR) 7.48 (7.44–7.51) 7.49 (7.46–7.52) 7.48 (7.44–7.5) 0.2
PaCO2, mmHg (IQR) 35 (30–40) 34 (30–37) 36 (30–42) 0.2
Blood lactate, mg/dl 
(IQR)
27 (14–40) 30 (18–40) 25 (12–40) 0.7
Serum creatinine, 
mg/dl (IQR)
0.68 (0.5–0.9) 0.6 (0.5–0.7) 0.8 (0.65–0.8) 0.4
PEEP, cmH2O (IQR) 8 (6.5–10) 8 (7.5–10) 8 (6–10) 0.7
PS, cmH2O (IQR) 10 (10–14) 11 (10–12) 11 (10–14) 0.3
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Data are presented as number (n) and percentage (%) for dichotomous values or median and interquartile 
range (IQR) for continuous values.
APACHE II, Acute Physiology and Chronic Health Evaluation II; ARDS, acute respiratory distress syndrome; 
BMI, body mass index; HACOR, Heart rate, Acidosis, Consciousness, Oxygenation and Respiratory rate; NIV, 
non-invasive mechanical ventilation; PEEP, positive end expiratory pressure; PS, pressure support; SAPS II, 
Simplified Acute Physiology Score; SOFA, Subsequent Organ Failure Assessment.
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Table 2. Clinical and physiological features of the study population at baseline and after 2 hours of 
NIV
Feature Overall NIV failure NIV success p
Baseline RR, bpm (IQR) 36 (27–44)) 34 (27–42) 36 (27–45) 0.8
RR after 2 hours of NIV, bpm (IQR) 30 (24–37) 31 (25–37) 30 (24–37) 0.6
Baseline ΔPL (ΔPes), cmH2O (IQR) 35 (26–40) 38 (32–42) 32.5 (24–39) 0.1
ΔPes after 2 hours of NIV, cmH2O (IQR) 19.5 (12–5–31) 31.5 (30–36) 11 (8–15) <0.0001
ΔPL after 2 hours of NIV, cmH2O (IQR) 37 (30–43) 39.5 (37.5–42.3) 30.5 (28–43.5) 0.04
Baseline VE, L/min (IQR) 28.1 (25.6–34.7) 28.3 (25.8–32.3) 27.4 (22.2–28.9) 0.6
VE after 2 hours of NIV, L/min (IQR) 23.3 (18.2–27.3) 27.2 (25–27.8) 19.8 (16.5–25) 0.07
Baseline Vte, ml/kg of PBW (IQR) 11 (9–12) 11 (9.5–12.3) 10.9 (9–11.2) 0.7
Vte after 2 hours of NIV, ml/kg of PBW 
(IQR)
11 (10–12) 11 (10–12.3) 10.8 (8.5–12) 0.5
Baseline Vte/ΔPL, ml/Kg/cmH2O (IQR) 0.32 (0-28-0.57) 0.31 (0.29-0.57) 0.33 (0.27-0.4) 0.3
Vte/ΔPL after 2 hours of NIV, 
ml/Kg/cmH2O  (IQR)
0.31 (0.25-0.39) 0.36 (0.21-0.44) 0.29 (0.26-0.31) 0.1
HACOR score (IQR) 6 (5–8) 6.5 (4.8–8) 6 (6–7) 0.5
HACOR score after 2 hours of NIV (IQR) 6 (5–6) 6 (4.8–6.5) 5.5 (4–6) 0.4
Data are presented as number and percentage for dichotomous values or median and interquartile range 
(IQR) for continuous values.
HACOR, Heart rate, Acidosis, Consciousness, Oxygenation and Respiratory rate; NIV, non-invasive 
mechanical ventilation; PBW, predicted body weight; ΔPes, change in esophageal pressure; ΔPL, change in 
dynamic transpulmonary pressure; RR, respiratory rate; VE, minute ventilation; Vte, expiratory tidal 
volume, Vte/ΔPL, expiratory tidal volume on transpulmonary pressure ratio.
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Table 3. Association between physiological and clinical variables and NIV failure at 24 hours
Feature OR 95%CI p
ΔPes < 10 cmH2O post 2h NIV 15 2.8–110 0.001
Vte > 9.5 ml/kg of PBW 7.9 1.5–72 0.02
HACOR score > 5 post 2h NIV 6.3 0.9–49 0.046
RR > 30 bpm 5.5 0.8–112 0.14
PaO2/FiO2 < 150 mmHg 2 0.5–9.8 0.4
Vte/ΔPL < 0.33 ml/Kg/cmH2O 2 0.4-9.8 0.36
Data are presented as odds ratio and 95%CI.
OR, odds ratio; NIV, non-invasive mechanical ventilation; PBW, predicted body weight; ΔPes, change in 
esophageal pressure; RR, respiratory rate; Vte, expiratory tidal volume, Vte/ΔPL, expiratory tidal volume on 
transpulmonary pressure ratio.
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Supplementary material
Figure E1. Time course assessment through ANOVA analysis of ΔPes (panel A), ΔPL (panel B), and 
ΔPes/ΔPL (panel C) for patients who failed and who were successful in the 24-hour NIV trial.
Figure E2. Time course assessment through ANOVA analysis of Vte/kg of PBW (panel A), VE (panel 
B), and Vte/ΔPL panel C) for patients who failed and who were successful in the 24-hour NIV trial .
Figure E3. Time course assessment through ANOVA analysis of RR (panel A), PaO2/FiO2 ratio (panel 
B), and HACOR score (panel C) for patients who failed and who were successful in the 24-hour NIV 
trial.
Figure E4. Correlation between ΔPes and Vte/ΔPL values on admission (r=-0.77, p<0.0001).
Figure E5. Correlation between ΔPes and PaO2/FiO2 ratio (panel A, r=–0.01, p=0.9), RR (panel B, 
r=0.23, p=0.2), HACOR score (panel C, r=0.05, p=0.8), and Vte/kg of PBW (panel D, r=–0.05, p=0.8) 
on admission.
Figure E6. Correlation assessed through Pearson’s correlation coefficient between ΔPes changes 2 
hours after NIV start and radiographic changes on chest X-ray assessed at 24 hours. Colored panels 
correspond to categories of radiographic change as assessed by the radiologist (from left to right: 
relevant worsening, worsening, mild worsening, unmodified, mild improvement, improvement, 
relevant improvement).
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Figure E7. Probability to die at 30 days from admission according to the reduction of ΔPes within the 
first 2 hours after NIV start.
Table E1. Sensitivity and specificity table derived from ROC analysis of ΔPes changes after 2 hours of 
NIV on NIV failure. 
Table E2. Sensitivity and specificity table derived from ROC analysis of baseline Vte/ΔPL on NIV 
failure. 
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At a Glance Commentary
Scientific Knowledge on the Subject. Non-invasive mechanical ventilation (NIV) is becoming 
increasingly used to assist spontaneous breathing during acute hypoxic de novo respiratory failure 
(AHRF), even though its potential therapeutic effect in this setting is controversial. Reported data 
show that NIV is used in 15% of patients with acute respiratory distress syndrome (ARDS) 
irrespective of the severity of respiratory failure and it seems to be associated with higher mortality 
in the case of failure. Several predictors of NIV failure in AHRF have been investigated but were 
found to be insufficient to aid the timing of endotracheal intubation. Thus, there is a need for an 
early robust predictor of NIV failure to avoid intubation delay.
What This Study Adds To The Field. Our exploratory study shows that, in patients with moderate 
to severe AHRF who were candidates for a 24-hour NIV trial, the magnitude of inspiratory effort 
relief was an early and accurate predictor of NIV failure. Our study suggests that monitoring of 
esophageal pressure might assist clinicians in the timing of intubation for patients with AHRF 
undergoing a NIV trial.
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Abstract
Rationale
The role of inspiratory effort has still to be determined asAmong the a potential predictors of non-
invasive mechanical ventilation (NIV) failure in acute hypoxic de novo respiratory failure (AHRF), the 
precise role of inspiratory effort has to be determined.
Objectives
We explore the hypothesis that, in patients with AHRF undergoing a NIV trial, inspiratory effort 
might be a major determinant of NIV failure in these patients.
Methods
Thirty consecutive patients with AHRF admitted to the Respiratory Intensive Care Unit of asa single 
center and candidates for a 24-hour NIV trial were enrolled in this study. Clinical features, tidal 
changes in esophageal (ΔPes) and dynamic transpulmonary pressure (ΔPL), expiratory tidal volume, 
and respiratory rate were recorded on admission and 2, -4, -12, and- 24 hours after NIV start, and 
were tested for correlation with NIV outcome and chest X-ray at 24 hoursoutcomes.
Measurements and Main Results
ΔPes and ΔPes/ΔPL ratios were significantly lower 2 hours after NIV start in those patients who 
successfully completed the NIV trial (n=18) compared to those who failed needed endotracheal 
intubation (n=12) [median=11 (IQR=8–15) cmH2O vs 31.5 (30–36) cmH2O, p<0.0001 and 0.71 (0.78–
0.86) vs 0.35 (0.43–0.50), p<0.0001, respectively] while other variables differed later. ΔPes was not 
related to other predictors of NIV failure at baseline. A significant correlation was found between 
ΔPes variation within the first 2 hours of NIV and chest X-ray worsening (p=0.0035). NIV-induced 
reduction in ΔPes changes <of 10 cmH2O or more within the firstafter 2 hours of NIV weretreatment 
was stronger strongly associated to avoidance of intubation, and represented the most accurate 
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predictor of treatment successand more accurate predictors of NIV failure among those tested 
(OR=15, 95%CI 2.8-110, p=0.001, AUC=0.97, 95%CI 0.91–1, p<0.0001).
Conclusions
The magnitude of inspiratory effort relief as assessed by ΔPes variation within the first 2 hours of NIV 
was an early and accurate predictor of NIV outcome at 24 hours.
Number of words in Abstract: 280232
Key words: acute respiratory distress syndrome, respiratory failure, non-invasive mechanical 
ventilation, transpulmonary pressure, esophageal pressure swings
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Introduction
The role of assisted spontaneous breathing (SB) in patients with acute hypoxic de novo respiratory 
failure (AHRF) is still controversial. When acute lung injury is mild, SB is desirable to preserve 
respiratory muscle function, improve the ventilation/perfusion ratio and regional ventilation (1), 
and reduce sedation and days of invasive mechanical ventilation (MV) (2). On the other hand, recent 
studies have suggested that SB might be a potential mechanism for lung damage if acute respiratory 
distress is severe (3). In recent years, non-invasive mechanical ventilation (NIV) has been 
increasingly used to assist SB in the intensive care setting, even though its potential therapeutic 
effect in AHRF is still debated. It has been reported that NIV is used in 15% of patients with acute 
respiratory distress syndrome (ARDS) irrespective of the severity of respiratory failure and it seems 
to be associated with higher mortality when PaO2/FiO2 is lower than 150 mmHg (4). Moreover, some 
studies have shown that NIV failure is associated with increased mortality in patients with AHRF 
(4,5); however, when NIV treatment is successful, it might considerably reduce the risk of death and 
length of ICU stay in this subset of patients (5).
Despite the fact that several potential factors associated with NIV failure have been investigated in 
hypoxic patients, there are no robust predictors that might alert the intensivist to the need for 
endotracheal intubation (ETI) within the very first hours of ventilation (6). Although the mechanisms 
behind the association between NIV failure and poorer survival remain unclear, a potential role for 
SB might be hypothesized. When SB is preserved during AHRF, the intensity of inspiratory effort may 
follow a critical increase in respiratory drive thus producing uncontrolled swings in transpulmonary 
pressure (PL) that would increase the risk of injury to the dependent lung and predispose the patient 
to the onset of self-inflicted lung injury (SILI) (6). The underlying mechanisms of SILI are 
heterogeneous and include the pendelluft phenomenon, increased transvascular pressure gradient 
aggravating alveolar damage, excessive diaphragmatic loading with impaired systemic oxygen 
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delivery, and muscle injury (3,7–9).
In this study, we explore the hypothesis that, in patients with moderate or severe AHRF undergoing 
a NIV trial, the excessive spontaneous effort of the patients, measured with esophageal pressure 
swings (ΔPes), may be a major determinant of NIV failure at 24 hours.
Methods
Study population
This prospective observational cohort study was carried out in a single eight-bed Respiratory 
Intensive Care Unit (RICU) at the University Hospital of Modena (I) following approval from the 
Ethics Committee “Area Vasta Emilia Nord” (registered protocol number 4485/C.E., document 
266/16). After testing our study hypothesis in 4 patients (pilot data not included in the analysis) 
during the period October 2016 to December 2018, the study has been registered retrospectively 
on ClinicalTrial.gov (ID NCT03826797). Thirty consecutive patients were then enrolled in between 
February and October 2019. Written informed consent to participate in the study and to analyze 
and divulgate clinical data was obtained from all patients admitted.
Inclusion criteria were age > 18 years and the presence of AHRF with PaO2/FiO2 ratio < 200 mmHg 
despite high-flow nasal oxygen with flow set at 60 L/min, and a candidate to receive a NIV trial 
according to the attending RICU staff, whose decision was taken upon clinical conditions blinded to 
the purpose of the study. Patients were excluded in the case of a previously established diagnosis 
of chronic obstructive pulmonary disease; diagnosed pulmonary embolism; neuromuscular disease; 
cardiogenic acute pulmonary edema; interstitial lung disease; chest wall deformities; the need for 
immediate endotracheal intubation (ETI) as represented by any of the following: cardiopulmonary 
arrest; respiratory arrest; loss of consciousness with respiratory pauses; psychomotor agitation 
requiring sedation; pH less than 7.20; neurological deterioration or massive secretions; 
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hemodynamic instability or major electrocardiographic abnormalities; pregnancy; intolerance to 
NIV; hypercapnic respiratory failure of any etiology (PaCO2 > 45 mmHg); home long-term oxygen 
therapy; denied informed consent.
Study procedures
General measures
Demographics and relevant comorbidities were assessed on admission. Clinical severity as assessed 
by the Kelly Scale, the Acute Physiology and Chronic Health Evaluation II (APACHE II) score, the 
Simplified Acute Physiology Score (SAPS II), the Subsequent Organ Failure Assessment (SOFA) score 
and the Heart rate, Acidosis, Consciousness, Oxygenation and Respiratory rate (HACOR) score were 
assessed and recorded on admission and after 2, 4, 12, and 24 hours. Arterial blood gases (PaO2-
PaCO2), pH, PaO2/FiO2 ratio, respiratory rate (RR), and blood lactate values were recorded before 
NIV start and 2, 4, 12, and 24 hours later. A chest X-ray was taken on admission and 24 hours after 
NIV start.
Physiological measurements
A multifunctional nasogastric tube with a dedicated pressure transducer (NutriVentTM, SIDAM, 
Mirandola, Italy) was placed before starting NIV. The nasogastric tube was connected to a dedicated 
monitoring system (OptiVentTM, SIDAM, Mirandola, Italy) to record swings in esophageal (Pes) and 
dynamic transpulmonary (PL) pressures. In order to avoid using absolute values for Pes and PL, we 
always refer to ΔPes and ΔPL from the end-expiratory level, respectively (10). Appropriate catheter 
position was confirmed by visualization of cardiac artifacts on Pes traces and radiopaque markers on 
chest X-rays, and validation of esophageal pressure measurements was obtained through dynamic 
occlusion tests (11,12). ΔPes was calculated as the negative deflection of Pes from the onset of 
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inspiratory effort. ΔPL was as the tidal change in transpulmonary pressure, calculated as airway 
pressure (Paw) minus Pes (10). 
ΔPes, ΔPL, and ΔPes/ΔPL ratios were assessed on admission and 2, 4, 12, and 24 hours after NIV start. 
Initial measurements were performed at each pre-specified time point while the patient was 
breathing spontaneously through the ventilator circuit. Data were sampled at 100 Hz and processed 
on a dedicated data acquisition system (OptiVentTM, SIDAM, Mirandola, Italy) (12). Data sampling 
was numerically stored and downloaded via USB stick at each time of assessment. Offline breath-
by-breath analysis was then performed for each measurement then averaged by a specific software 
(Flux View Respiratory Mechanics Monitor (NBMED- Medical Graphics, Milano, Italy). For all the 
measurements the beginning of the inspiratory phase was identified at the instant of Pes initial decay 
while the end of inspiration considered at the point of Pes that elapsed 25% of time from its 
maximum deflection to return to baseline.  
Respiratory flow was measured by an external heated Fleisch No. 2 pneumotachograph (Fleisch, 
Lausanne, Switzerland) inserted between the patient’s oronasal facemask (BluestarTM, KOO Medical 
Equipment, Shanghai, PRC) and a connector with a side port for mechanical measurement. 
Expiratory tidal volume (Vte) was obtained by numerical integration of the flow signal. Vte was then 
adjusted to the predicted body weight (PBW) to derive Vte/kg of PBW. Vte/kg of PBW was assessed 
on admission and 2, 4, 12 and 24 hours after NIV start. Minute ventilation (VE) was calculated as the 
product of Vte and RR and assessed on admission and 2, 4, 12 and 24 hours after NIV start. Vte/ΔPL 
was further measured at each pre-defined time point.
Leaks from the oronasal facemask were computed using dedicated ventilator-integrated software 
(GE Healthcare Engstrom CarestationTM, GE Healthcare, Finland) based on the equation: leaks 
(L/min) = (inspiratory Vt – expiratory Vt) x RR.
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All measurements were performed during a stable spontaneous breathing pattern of 5 minutes and 
results were averaged for each assessment step.
NIV treatment
After NutriventTM placement, NIV was started and set by a respiratory physician with expertise in 
Respiratory Intensive Care. Patients were connected via a conventional circuit with an appropriately 
sized oronasal facemask equipped with a dedicated output for probes (BluestarTM, KOO Medical 
Equipment, Shanghai, PRC) to a high-performance ventilator (GE Healthcare Engstrom 
CarestationTM, GE Healthcare, Finland) in pressure support pre-set mode. Heat and moisture 
exchanger (HME) (HYGROBAC, DAR, Mirandola, Italy) was placed to the ventilator circuit's Y-piece. 
Positive end expiratory pressure (PEEP) was initially set at 6 cmH2O, and subsequently fine-tuned 
(4–8 cmH2O) in order to target a SatO2 > 92% with a delivered FiO2 less than 70%. Pressure support 
(PS) was set at 10 cmH2O, and then progressively modified, according to tidal volume (Vte/kg of 
PBW), in order to target a Vte/kg of PBW lower than 9.5 ml/kg of PBW and a RR lower than 30 
breaths/min. The oronasal facemask was finely adjusted to target a leak flow lower than 20 L/min. 
The inspiratory trigger was set at 3 L/min and respiratory cycling was set at 25% of the inspiratory 
peak flow. Great care was taken by the nurses in charge of NIV, and who were blinded to the 
protocol, to avoid any possible air leaks. The inspiratory fraction of oxygen delivered (FiO2) was 
increased to target a transcutaneous oxyhemoglobin saturation of 88–94%. Setting was adjusted by 
the attending physician blinded to the study purpose and based on blood gases and/or continuous 
oxymetry assessment. Patients receiving NIV treatment were not sedated. The decision as to 
whether to proceed to ETI at 24 hours after NIV start was taken according to best clinical practice 
by the attending RICU staff, blinded to the results of the physiological assessment acquired through 
the OptiventTM monitor only at each pre-defined time point. NIV failure was defined by the onset of 
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the need for ETI or by death. Criteria for ETI included: (a) PaO2/FiO2 ratio unchanged or worsened 
or below 150 mmHg, (b) the need to protect airways due to neurological deterioration or massive 
secretions, (c) hemodynamic instability or major electrocardiographic abnormalities, (d) unchanged 
or worsened dyspnea and persistence of respiratory distress (RR > 35 bpm, gasping for air, 
psychomotor agitation requiring sedation, abdominal paradox).
Outcome measures
The influence of ΔPes on NIV failure or success at 24 hours was pre-specified as a primary outcome. 
The impact of ΔPL, ΔPes/ΔPL ratio, PaO2/FiO2 ratio, RR, Vte/kg of PBW, Vte/ΔPL, VE and the HACOR 
score on NIV outcome at 24 hours and the correlation between ΔPes and radiographic changes on 
chest X-ray within the first 24 hours after NIV start were assessed as secondary outcomes. 
Radiographic changes on chest X-ray within the first 24 hours after admission were assessed by a 
radiologist with expertise in chest X-ray and blinded to the purpose of the study. Changes were 
classified as follows: relevant worsening, worsening, mild worsening, unmodified, relevant 
improvement, improvement, mild improvement.
Statistical analysis
The statistical package GraphPad Prism 8.0 (GraphPad Software, Inc., La Jolla, CA, USA) was used for 
statistical analysis. Due to the exploratory nature of the study, no sample size calculation was 
performed. Descriptive statistics was used to characterize the study population as a whole and 
according to primary outcome. The nonparametric Mann–Whitney and Student t test were used for 
the comparison of continuous variables. Comparison between dichotomous variables was 
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performed by the χ2 test or Fisher's exact test, where appropriate. The time course of ΔPes, ΔPL, 
ΔPes/ΔPL ratio, PaO2/FiO2 ratio, Vte/kg of PBW, Vte/ΔPL, RR, VE and HACOR score according to NIV 
outcome within the first 24 hours of treatment was assessed through ANOVA analysis. Then a post-
hoc Bonferroni-Dunn’s multiple test was used to perform the pairwise comparison of means for 
each analyzed variable at the prespecified time points. The correlation between baseline values of 
ΔPes and PaO2/FiO2, Vte, RR, HACOR score, Vte/ΔPL and the chest X-ray radiographic categories was 
assessed through Pearson’s correlation coefficient. The impact of ΔPes change within 2 hours after 
NIV start and baseline value of Vte/ΔPL on NIV outcome was assessed through a logistic regression 
model. A receiver operating characteristic (ROC) analysis was then performed to identify the best 
predictive cut-off for ΔPes change within 2 hours after NIV start and for baseline Vte/ΔPL. The 
association between the best cut-off value of ΔPes change after 2 hours of NIV and baseline Vte/ΔPL, 
Vte > 9.5 ml/kg of PBW, RR > 30 bpm, PaO2/FiO2 ratio < 150 mmHg and HACOR score > 5 within 2 
hours after NIV start on NIV failure at 24 hours was then tested through univariate logistic regression 
analysis. ROC analysis was used to assess the accuracy in predicting NIV failure at 24 hours for all 
the analyzed variables at pre-specified cut offs. Then, at 30 days, survival analysis was performed 
through a log-rank test for ΔPes change within 2 hours after NIV start. A p-value less than 0.05 was 
considered to be statistically significant.
Results
Patient characteristics
Over the study period, 30 out of 86 consecutive patients admitted for AHRF to the RICU of the 
University Hospital of Modena (Italy) and who were candidates to receive a NIV trial were enrolled 
in this study. Of these, 12 patients (40%) experienced NIV failure within 24 hours after NIV start. 
Those patients for which the need for ETI was defined at 24 hours as the “alert” criterion of our 
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internal guideline, were thereafter intubated by the RICU staff.  Of those who were successful in the 
24-hour trial (60%), none were further intubated during their RICU stay. The flow chart for patients 
in this study is shown in Figure 1.
The general features and clinical characteristics of the whole population at baseline and according 
to NIV outcome at 24 hours are presented in Table 1. None of the features assessed were 
significantly different between the two groups of patients (NIV failure vs NIV success) at baseline. In 
particular, the overall population presented an average value of PaO2/FiO2 of 125 (interquartile 
range [IQR] 101–170) mmHg, which did not differ significantly according to NIV outcome at 24 hours 
(100 [118–141] mmHg and 111 [132–173]) mmHg, respectively, p=0.5). All patients with ARDS 
(n=15) presented pulmonary ARDS. In 10 patients, the etiology was identified as infectious (bacterial 
n=4, fungal n=2, viral n=4) while for 5 patients, no etiological diagnosis was made. Patients with 
pneumonia had unilateral lung consolidation and 9 of them presented a bacterial infectious cause 
(Streptococcus pneumoniae n=4, intracellular pathogens n=4, Hemophilus influenzae n=1). The 
presence of pneumonia and ARDS was equally distributed between the two groups (42% vs 44% 
p>0.9, 58% vs 44% p=0.7, respectively).
Physiological measurements and NIV outcome
Table 2 shows the physiological dynamic respiratory mechanics for the whole population at baseline 
and in the NIV outcome subgroups at baseline and after 2 hours of NIV. At baseline, the median 
value of ΔPes was 34 (26–40) cmH2O. Of note, none of the physiological features analyzed were 
significantly different at baseline between the two groups. After 2 hours of NIV, the median value 
of ΔPes was significantly lower for those patients who were successful in the 24-hour NIV trial 
compared to patients who failed (11 [8–15] cmH2O vs 31.5 [30–36] cmH2O, p<0.0001). Moreover, 
these latter patients presented a significantly increased value of ΔPL once NIV had started compared 
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to patients who experienced NIV success at 24 hours (39.5 [37.5–42-3] cmH2O vs 30.5 [28–43.5] 
cmH2O, p=0.04). 
Figure 2, panel A shows ΔPes changes from baseline within the first 2 hours of NIV for the whole 
population and according to NIV outcome at 24 hours. ΔPes decreased significantly after 2 hours of 
NIV for the whole population and for those patients who were successful in the NIV trial, whereas 
it did not change for patients who experienced NIV failure. Moreover, only these latter patients 
presented a significant increase in ΔPL after 2 hours of NIV (Figure 2, panel B).
Waveform analysis of ΔPL and ΔPes swings 2 hours after NIV start is displayed in Figure 3, for a patient 
who failed the 24-hour NIV trial (panels A and C) and for a patient who succeeded (panels B and D). 
The time course of the physiological and clinical variables (ΔPes, ΔPL, ΔPes/ΔPL, RR, PaO2/FiO2 ratio, 
HACOR score, Vte/kg of PBW, Vte/ΔPL, and VE) in the two categories of patients according to NIV 
outcome showed a significant improvement over time in patients who were successful in the NIV 
trial. Moreover, only ΔPes significantly decreased earlier (2 hours after NIV start) in those patients 
who were successful in the NIV trial compared to those who failed (p<0.0001, Figure E1A, 
supplementary material). The ratio between ΔPes and ΔPL was significantly different 2 hours after 
NIV start between the two groups (p<0.0001, Figure E1C, supplementary material), while ΔPL 
(p=0.04, Figure E1B, supplementary material ), Vte/kg of PBW, VE, Vte/ΔPL (p=0.01, p=0.01, and 
p=0.001, Figure E2, panel A, B, C, respectively, supplementary material), RR, PaO2/FiO2, HACOR 
score (p=0.02, p<0.0001, and p=0.03, Figure E3, panel A, B, C, respectively, supplementary material) 
were all significantly different more than 2 hours after NIV start.
Significant inverse correlation was found between baseline ΔPes and Vte/ΔPL (r=-077, p<0.0001, 
Figure E4 supplementary material). No significant correlation was found between baseline ΔPes and 
PaO2/FiO2 ratio (r=–0.01, p=0.9, Figure E5, panel A supplementary material), RR (r=0.23, p=0.2, 
Figure E5, panel B supplementary material), HACOR score (r=0.05, p=0.8, Figure E5, panel C 
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supplementary material), and Vte/kg of PBW (r=–0.05, p=0.8, Figure E5, panel D supplementary 
material). 
Radiological changes and inspiratory effort
The correlation analysis performed for radiographic changes showed that patients with a greater 
reduction in ΔPes 2 hours after NIV start experienced more consistent improvements on chest X-ray 
at 24 hours, whereas patients with a limited reduction of ΔPes were those who showed a 
deterioration on chest X-ray (Figure E6, supplementary material).
Inspiratory effort and clinical outcome
In the logistic regression model, ΔPes changes within the first 2 hours of NIV showed a significant 
association with NIV failure at 24 hours (odds ratio [OR]=1.7, 95%CI 1.2–3, p=0.01) while baseline 
Vte/ΔPL was not significantly associated with NIV outcome (p=.03). From ROC analysis, ΔPes changes 
< 10 cmH2O gave the most accurate cut-off value for prediction of NIV failure (sensitivity 0.91 95%CI 
0.65–1, specificity 0.83 95%CI 0.61–0.94, likelihood ratio=5.5, positive predictive value=0.79, 95%CI 
0.52–0.92, negative predictive value=0.94 95%CI 0.72–1, Table E1, supplementary material);  
Vte/ΔPL < 0.33 ml/Kg/cmH2O showed the best cut-off value for prediction of NIV failure (sensitivity 
0.67 95%CI 0.40–0.86, specificity 0.5 95%CI 0.29–0.71, likelihood ratio=1.3, positive predictive 
value=0.47, 95%CI 0.26–0.7, negative predictive value=0.7 95%CI 0.42–87, Table E2, supplementary 
material. When univariate logistic regression was applied to the pre-specified potential predictors 
of NIV failure, ΔPes changes < 10 cmH2O showed the highest association with NIV failure at 24 hours 
(OR=15 95%CI 2.8–110, p=0.001). Among the other predictors tested, Vte > 9.5 ml/kg of PBW and 
HACOR > 5 after 2 hours of NIV were significantly associated with NIV failure at 24 h (OR=7.9 95%CI 
1.5–72, p=0.02 and OR=6.3 95%CI 0.9–49, p=0.046, respectively) while RR > 30 bpm, PaO2/FiO2 ratio 
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< 150 mmHg and Vte/ΔPL < 0.33 ml/Kg/cmH2O, although strongly associated, did not reach 
statistical significance (Table 3). From ROC analysis, ΔPes changes < 10 cmH2O within the first 2 
hours after NIV start showed higher accuracy in predicting NIV failure (AUC=0.97 95%CI 0.91–1, 
p<0.0001) (Figure 4) than baseline Vte > 9.5 ml/kg of PBW, HACOR score > 5, RR > 30 bpm, PaO2/FiO2 
ratio < 150 mmHg and Vte/ΔPL < 0.33 ml/Kg/cmH2O (AUC=0.88 95%CI 0.76–0.99, p=0.0005, 
AUC=0.85 95%CI 0.71–0.99, p=0.00, AUC=0.83 95%CI 0.67–0.98, p=0.003, AUC=0.74 95%CI 0.56–
0.92, p=0.03, AUC= 0.58 95%CI 0.37-0.8, p=0.44, respectively).
Kaplan–Meier curves showed a significant increase in 30-day mortality among patients with ΔPes 
reduction < 10 cmH2O within the first 2 hours after NIV start compared to patients with a more 
consistent early improvement (HR=4.5 95%CI 1.01–17.9, p=0.048, Figure E7 supplementary 
material).
Discussion
In this exploratory study, patients with moderate to severe AHRF undergoing a NIV trial presented 
a median baseline value for ΔPes of 34 cmH2O that was significantly reduced within the first 2 hours 
of ventilation in patients who were successful in the NIV trial, while those patients failing NIV did 
not have a significantly reduced ΔPes. This study therefore shows that a significant ΔPes reduction 
within the first 2 hours of NIV start was an early and accurate predictor of NIV outcome and was 
significantly correlated with radiographic changes after 1 day of NIV. Moreover, the magnitude of 
inspiratory effort at baseline did not show a significant correlation with the severity of respiratory 
failure, tidal volume, RR, and HACOR score on admission.
Physiological measurements and NIV outcome
Early prediction of NIV failure in moderate to severe AHRF
The application of NIV in treating patients with AHRF is a controversial issue and it is currently used 
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in clinical practice irrespective of the severity of PaO2/FiO2. Despite the initial promising results on 
the effectiveness of NIV in patients with hypoxic respiratory failure (13,14), more recent studies 
focusing on patients with AHRF and excluding underlying chronic respiratory diseases or cardiogenic 
pulmonary edema warn of the increased mortality rates once ETI is delayed (5,15,16). Despite the 
fact that failure rates can exceed 60% in patients with more severe AHRF, successful application of 
NIV is independently associated with survival and shorter length of ICU stay (5). Giving these 
assumptions, it seems of critical interest to identify early predictors of NIV failure in order to avoid 
deleterious intubation delay in this subset of patients.
Previous studies have shown that several factors (i.e. higher severity score on admission, older age, 
ARDS or pneumonia as the etiology for acute respiratory failure, or a lack of improvement in blood 
gas exchange within 1 hour of treatment) are associated with NIV failure in patients with AHRF, 
although these were insufficient to influence ETI timing (17). In our study, all of these factors were 
not different in patients who failed the 24-hour NIV compared to patients who were successful in 
the trial. In a recent single-center study, Duan and coworkers developed and validated the HACOR 
score for prediction of NIV failure in patients with AHRF, showing that patients with a HACOR score 
greater than 5 after the first hour of NIV were at greater risk for NIV failure and, if switched to 
invasive mechanical ventilation (MV) within the first 12 hours, presented reduced in-hospital 
mortality (18). In our study, the HACOR score was significantly associated with increased NIV failure 
but not as early as ΔPes. Moreover, both groups of patients presented a HACOR score greater than 
5 after the first 2 hours of NIV. Two recent studies have demonstrated that moderate-to-severe 
hypoxemia significantly affects NIV outcome in patients with ARDS-induced AHRF (19,20). Our study 
presented a carefully selected population of patients with moderate to severe AHRF, whose average 
PaO2/FiO2 was 132 mmHg and in whom significant differences between those who were successful 
in the NIV trial compared to those who were subjected to ETI did not become evident until 12 hours 
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after the start of NIV. Of interest, the inspiratory effort at baseline as expressed by ΔPes did not show 
a significant correlation with the severity of respiratory failure. These findings are in line with data 
reported in a recent physiological study by Grieco et al. where ΔPe was unrelated to oxygenation 
impairment during helmet NIV and high flow oxygen treatment (21). Our data further underline the 
inability of PaO2/FiO2 ratio alone to identify patients with harmful respiratory drive.
In a recent trial, Carteaux and coworkers showed that a Vte value greater than 9.5 mL/kg was 
independently associated with NIV failure in patients with AHRF (22) suggesting a role of high Vte 
as a potential predictor of NIV failure in this setting (19). The results from our study are in line with 
their reported data although significant differences in Vte between patients who failed the NIV 
treatment and those who were successful became evident 12 hours after NIV start. Moreover, the 
magnitude of inspiratory effort was not correlated with average Vte at baseline. Considering these 
data, the inability to apply protective ventilation should be considered a critical mechanism of NIV 
failure in this subset of patients.
The main result from our study was that a change in ΔPes less than 10 cmH2O within the first 2 hours 
after NIV start was an early and accurate predictor of NIV failure at 24 hours when compared to 
other variables, such as PaO2/FiO2, Vte, HACOR, and RR. From a clinical point of view, these data 
might suggest that, in patients with moderate to severe AHRF, the effectiveness of a NIV trial should 
be related to the reduction in the patient’s inspiratory effort, quantifiable through esophageal 
manometry. The consequences of this reduction translate into a subsequent significant reduction 
of Vte, a decrease in RR, and an improvement in PaO2/FiO2 with a few hours latency. Moreover, the 
correlation analysis showed that ΔPes on admission was not associated with the baseline value of 
other predictors of NIV failure. 
Radiological changes and inspiratory effort
Inspiratory effort and self-inflicted lung injury during NIV
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Our results showed a significant correlation between ΔPes changes within the first 2 hours of NIV 
and radiographic progression at 24 hours. Despite being less accurate than a computed tomography 
scan, chest X-ray showed good sensitivity in detecting lung alteration in patients with ARDS (23) and 
might be considered reliable in the evaluation of the extent and distribution of lung opacities, once 
a diagnosis has already been made (24).
The results of our study support the hypothesis that inspiratory effort might be a potential 
mechanism of lung damage enhancement if acute respiratory distress is severe. Although data from 
animal models indicate ΔPL as a major determinant of SILI, experimental studies conducted on 
normal trained subjects during exhausting endurance exercise demonstrated that potentially 
injurious values of ΔPL (up to 52 cmH2O) did not translate into lung mechanical changes (25,26). To 
understand this, we have to consider that, in normal fluid-like lung, the inspiratory swing in pleural 
pressure produced by inspiratory effort is homogeneously distributed across the pleural surface. In 
contrast, in injured solid-like lung, the inspiratory pleural swing is not uniformly dissipated, resulting 
in a more negative deflection in the dependent lung zones with tidal over-recruitment and local 
overstretch (6). More recently, two trials investigating the role of assisted SB in mechanically 
ventilated patients showed that SB was not associated with poorer outcome when compared to 
controlled MV (27,28), but they lacked assessment of the inspiratory effort. Our results might 
suggest that a major determinant in generating lung stress lies in the dynamic component of the 
inspiratory effort rather than in the absolute value of the pressure generated. Interestingly, within 
the first 2 hours of NIV, ΔPes/ΔPL was different in those who were successful in the NIV trial 
compared to those who failed it. This ratio might express to what extent dynamic ΔPL is affected by 
the patient’s respiratory drive and might introduce a new insight in the understanding of SILI. In 
particular, for the same value of ΔPL, patients who presented higher values of ΔPes experienced a 
higher NIV failure rate. This mechanism alongside a Vt of more than 6 ml, high breathing frequency 
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and elevated mechanical power should be considered critical for SILI. These results highlight the 
potential role of the pendelluft phenomenon and negative pressure alveolar edema in determining 
SILI. Recently, in a rat model of acute lung injury, Henzler and coworkers showed that ΔPL was more 
important than inspiratory effort in generating ventilatory associated lung injury during partial 
ventilatory support (29). These results are apparently contradictory to those reported in our study, 
but some issue might have influenced the conclusions. First, the experimental PEEP was set at 5 
cmH2O which, in a murine model, is comparable to higher levels in larger animals, producing a sort 
of recruitment favoring a fluid-like behavior of the lung and reducing the harmful role of SB (25). 
Second, the animals ventilated with a lower level of support presented hypercapnic acidosis that 
might have mitigated the ventilatory-associated lung injury. Furthermore, in our study we have 
assessed the Vte/ΔPL as a surrogate of lung compliance in order to explore the concept of baby lung 
during NIV. Data show an inverse linear correlation between Vte/ΔPL and inspiratory effort (Figure 
E4, supplementary material). Moreover, the time course of this index resulted different between 
those who succeeded the 24 hours NIV trial as compared to those who failed (Figure E2, panel C, 
supplementary material). Thus, this might justify the discrepancies in the behavior of Vte and 
inspiratory effort. Although not significantly associated with NIV failure this index deserves further 
investigations in larger physiological trials. 
Limitations of the study
Our study has several limitations. First, the number of patients might have underpowered the 
results obtained. In particular, the value of ΔPes changes < 10 cmH2O should be confirmed in larger 
trials. Second, our study population was highly selected influencing the generalization of our results. 
In particular, none of the patients who were successful in the 24-hour trial required further 
intubation thus indicating that patients were enrolled very early in the course of the disease. Third, 
we did not carry out any assessment of inflammatory biomarkers. The determination of cytokine 
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levels might clarify the role of vigorous inspiratory effort in exaggerating lung injury. Moreover, as 
patients were studied during spontaneous breathing, what we measured was dynamic PL, thus the 
influence of the inspiratory and expiratory resistances on the measured pressures should be 
considered. Furthermore, we did not perform gastric pressure assessment, so ΔPes values may have 
been overestimated in the case of expiratory muscle recruitment. Finally, despite the fact that our 
study identifies ΔPes changes as the major and early physiological predictor of NIV failure, the 
evaluation of a composite parameter that takes into account the various components of the 
respiratory drive (including minute ventilation, respiratory rate, inspiratory flow rate and P0.1) as a 
bundle, might be of relevant clinical importance and should be assessed in further multicenter trials. 
At this time, we believe that this technique produces highly reliable data if managed in centers with 
expertise in esophageal manometry. Notwithstanding this, an increase in its use should raise the 
level of confidence in daily clinical practice.
Study key messagesConclusion
Even with the limitations described, our study highlights new concepts which can be summarized as 
follows: 1) patients with severe AHRF undergoing NIV may achieve harmful dynamic transpulmonary 
pressure levels, 2) the magnitude of inspiratory effort during NIV is the earliest and most accurate 
parameter that predicts failure, 3) the amount of inspiratory effort is not correlated with 
oxygenation, therefore PaO2/FiO2 ratio cannot be used as a surrogate of ΔPes, 4) the significant 
correlation between ΔPes changes within the first 2 hours of NIV and radiographic progression at 24 
hours suggest that SILI might be a potential mechanism of lung damage in these patients.
Conclusion
In the hypothesis of SILI as a critical factor affecting NIV failure in patients with AHRF, we found that 
the magnitude of inspiratory effort as assessed by ΔPes variation within the first 2 hours of NIV 
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treatment is an early and accurate predictor of outcome at 24 hours. The clinical implications of our 
study suggest that monitoring esophageal pressure might help clinicians in the making decision 
process (airway intubation) for patients with AHRF undergoing a NIV trial. Due to the exploratory 
nature of this study, findings should be confirmed in multicenter clinical trials.
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Figure legends
Fig. 1. Flow chart for patients in this study.
Fig. 2. (A) ΔPes changes from baseline within the first 2 hours of NIV for the whole population and 
according to NIV outcome at 24 hours. (B) ΔPL changes from baseline within the first 2 hours of NIV 
for the whole population and according to NIV outcome at 24 hours.
Fig. 3. Graphical representation of ΔPL and ΔPes waveform swings after 2 hours of NIV for a patient 
who failed the NIV trial at 24 hours (panels A and C) and for a patient who was successful (panels B 
and D). The beginning of the inspiratory phase was identified at the time of Pes initial decay, while 
the end of inspiration was considered at the point of Pes that elapsed 25% of time from its maximum 
deflection to return to baseline.  
Fig. 4. Receiver operating characteristic (ROC) analysis. ΔPes changes < 10 cmH2O within the first 2 
hours of NIV showed a high accuracy in predicting NIV failure (AUC=0.97, p<0.0001).
Page 65 of 83
For Review Only
27
Tables
Table 1. Baseline features of the study population presented as a whole or as NIV outcome at 24 
hours
Feature Overall NIV failure NIV success p
Number of patients 30 12 18
Age, years (IQR) 71 (66–81) 69 (62–80) 71 (68–81) 0.7
Male, n (%) 20 (67) 8 (67) 12 (67) >0.9
BMI, kg/m2 (IQR) 23 (19–27) 22.5 (18–26) 24 (21–27) 0.3
Charlson index, score 
(IQR)
4 (3–5.5) 4 (3–5) 4.5 (3–6) 0.6
Pneumonia, n (%) 13 (23) 5 (42) 8 (44) >0.9
ARDS, n (%) 15 (50) 7 (58) 8 (44) 0.7
Kelly scale, score 
(IQR)
1 (1–1) 1 (1–1) 1 (1–1) 0.4
APACHE II, score 
(IQR)
27 (21–38) 24.5 (19–45) 28 (25–37) 0.8
SAPS II, score (IQR) 36 (26–41) 36 (31–38) 36 (25–44) 0.6
SOFA, score (IQR) 6 (4–8.8) 5.5 (3–8) 6.5 (4–9) 0.6
PaO2/FiO2, mmHg 
(IQR)
125 (101–170) 118 (100–141) 133 (111–144) 0.5
pH, value (IQR) 7.48 (7.44–7.51) 7.49 (7.46–7.52) 7.48 (7.44–7.5) 0.2
PaCO2, mmHg (IQR) 35 (30–40) 34 (30–37) 36 (30–42) 0.2
Blood lactate, mg/dl 
(IQR)
27 (14–40) 30 (18–40) 25 (12–40) 0.7
Serum creatinine, 
mg/dl (IQR)
0.68 (0.5–0.9) 0.6 (0.5–0.7) 0.8 (0.65–0.8) 0.4
PEEP, cmH2O (IQR) 8 (6.5–10) 8 (7.5–10) 8 (6–10) 0.7
PS, cmH2O (IQR) 10 (10–14) 11 (10–12) 11 (10–14) 0.3
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Data are presented as number (n) and percentage (%) for dichotomous values or median and interquartile 
range (IQR) for continuous values.
APACHE II, Acute Physiology and Chronic Health Evaluation II; ARDS, acute respiratory distress syndrome; 
BMI, body mass index; HACOR, Heart rate, Acidosis, Consciousness, Oxygenation and Respiratory rate; NIV, 
non-invasive mechanical ventilation; PEEP, positive end expiratory pressure; PS, pressure support; SAPS II, 
Simplified Acute Physiology Score; SOFA, Subsequent Organ Failure Assessment.
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Table 2. Clinical and physiological features of the study population at baseline and after 2 hours of 
NIV
Feature Overall NIV failure NIV success p
Baseline RR, bpm (IQR) 36 (27–44)) 34 (27–42) 36 (27–45) 0.8
RR after 2 hours of NIV, bpm (IQR) 30 (24–37) 31 (25–37) 30 (24–37) 0.6
Baseline ΔPL (ΔPes), cmH2O (IQR) 35 (26–40) 38 (32–42) 32.5 (24–39) 0.1
ΔPes after 2 hours of NIV, cmH2O (IQR) 19.5 (12–5–31) 31.5 (30–36) 11 (8–15) <0.0001
ΔPL after 2 hours of NIV, cmH2O (IQR) 37 (30–43) 39.5 (37.5–42.3) 30.5 (28–43.5) 0.04
Baseline VE, L/min (IQR) 28.1 (25.6–34.7) 28.3 (25.8–32.3) 27.4 (22.2–28.9) 0.6
VE after 2 hours of NIV, L/min (IQR) 23.3 (18.2–27.3) 27.2 (25–27.8) 19.8 (16.5–25) 0.07
Baseline Vte, ml/kg of PBW (IQR) 11 (9–12) 11 (9.5–12.3) 10.9 (9–11.2) 0.7
Vte after 2 hours of NIV, ml/kg of PBW 
(IQR)
11 (10–12) 11 (10–12.3) 10.8 (8.5–12) 0.5
Baseline Vte/ΔPL, ml/Kg/cmH2O (IQR) 0.32 (0-28-0.57) 0.31 (0.29-0.57) 0.33 (0.27-0.4) 0.3
Vte/ΔPL after 2 hours of NIV, 
ml/Kg/cmH2O  (IQR)
0.31 (0.25-0.39) 0.36 (0.21-0.44) 0.29 (0.26-0.31) 0.1
HACOR score (IQR) 6 (5–8) 6.5 (4.8–8) 6 (6–7) 0.5
HACOR score after 2 hours of NIV (IQR) 6 (5–6) 6 (4.8–6.5) 5.5 (4–6) 0.4
Data are presented as number and percentage for dichotomous values or median and interquartile range 
(IQR) for continuous values.
HACOR, Heart rate, Acidosis, Consciousness, Oxygenation and Respiratory rate; NIV, non-invasive 
mechanical ventilation; PBW, predicted body weight; ΔPes, change in esophageal pressure; ΔPL, change in 
dynamic transpulmonary pressure; RR, respiratory rate; VE, minute ventilation; Vte, expiratory tidal 
volume, Vte/ΔPL, expiratory tidal volume on transpulmonary pressure ratio.
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Table 3. Association between physiological and clinical variables and NIV failure at 24 hours
Feature OR 95%CI p
ΔPes < 10 cmH2O post 2h NIV 15 2.8–110 0.001
Vte > 9.5 ml/kg of PBW 7.9 1.5–72 0.02
HACOR score > 5 post 2h NIV 6.3 0.9–49 0.046
RR > 30 bpm 5.5 0.8–112 0.14
PaO2/FiO2 < 150 mmHg 2 0.5–9.8 0.4
Vte/ΔPL < 0.33 ml/Kg/cmH2O 2 0.4-9.8 0.36
Data are presented as odds ratio and 95%CI.
OR, odds ratio; NIV, non-invasive mechanical ventilation; PBW, predicted body weight; ΔPes, change in 
esophageal pressure; RR, respiratory rate; Vte, expiratory tidal volume, Vte/ΔPL, expiratory tidal volume on 
transpulmonary pressure ratio.
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Supplementary material
Figure E1. Time course assessment through ANOVA analysis of ΔPes (panel A), ΔPL (panel B), and 
ΔPes/ΔPL (panel C) for patients who failed and who were successful in the 24-hour NIV trial.
Figure E2. Time course assessment through ANOVA analysis of Vte/kg of PBW (panel A), VE (panel 
B), and Vte/ΔPL panel C) for patients who failed and who were successful in the 24-hour NIV trial .
Figure E3. Time course assessment through ANOVA analysis of RR (panel A), PaO2/FiO2 ratio (panel 
B), and HACOR score (panel C) for patients who failed and who were successful in the 24-hour NIV 
trial.
Figure E4. Correlation between ΔPes and Vte/ΔPL values on admission (r=-0.77, p<0.0001).
Figure E5. Correlation between ΔPes and PaO2/FiO2 ratio (panel A, r=–0.01, p=0.9), RR (panel B, 
r=0.23, p=0.2), HACOR score (panel C, r=0.05, p=0.8), and Vte/kg of PBW (panel D, r=–0.05, p=0.8) 
on admission.
Figure E6. Correlation assessed through Pearson’s correlation coefficient between ΔPes changes 2 
hours after NIV start and radiographic changes on chest X-ray assessed at 24 hours. Colored panels 
correspond to categories of radiographic change as assessed by the radiologist (from left to right: 
relevant worsening, worsening, mild worsening, unmodified, mild improvement, improvement, 
relevant improvement).
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Figure E7. Probability to die at 30 days from admission according to the reduction of ΔPes within the 
first 2 hours after NIV start.
Table E1. Sensitivity and specificity table derived from ROC analysis of ΔPes changes after 2 hours of 
NIV on NIV failure. 
Table E2. Sensitivity and specificity table derived from ROC analysis of baseline Vte/ΔPL on NIV 
failure. 
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Fig. 1. Flow chart for patients in this study. 
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Sensitivity% 95% CI Specificity% 95% CI Likelihood 
ratio
> -28.00 100,0 75,75% to 
100,0%
5,556 0,2850% to 
25,76%
1,059
> -26.50 100,0 75,75% to 
100,0%
11,11 1,974% to 
32,80%
1,125
> -24.00 100,0 75,75% to 
100,0%
16,67 5,837% to 
39,22%
1,200
> -21.50 100,0 75,75% to 
100,0%
27,78 12,50% to 
50,87%
1,385
> -20.65 100,0 75,75% to 
100,0%
33,33 16,28% to 
56,25%
1,500
> -19.15 100,0 75,75% to 
100,0%
38,89 20,31% to 
61,38%
1,636
> -17.50 100,0 75,75% to 
100,0%
44,44 24,56% to 
66,28%
1,800
> -16.50 100,0 75,75% to 
100,0%
55,56 33,72% to 
75,44%
2,250
> -15.50 100,0 75,75% to 
100,0%
61,11 38,62% to 
79,69%
2,571
> -14.50 100,0 75,75% to 
100,0%
66,67 43,75% to 
83,72%
3,000
> -12.50 100,0 75,75% to 
100,0%
77,78 54,79% to 
91,00%
4,500
> -10.00 91,67 64,61% to 
99,57%
83,33 60,78% to 
94,16%
5,500
> -9.000 83,33 55,20% to 
97,04%
83,33 60,78% to 
94,16%
5,000
> -7.500 83,33 55,20% to 
97,04%
94,44 74,24% to 
99,72%
15,00
> -6.500 75,00 46,77% to 
91,11%
100,0 82,41% to 
100,0%
> -5.500 66,67 39,06% to 
86,19%
100,0 82,41% to 
100,0%
> -3.500 58,33 31,95% to 
80,67%
100,0 82,41% to 
100,0%
> -1.000 50,00 25,38% to 
74,62%
100,0 82,41% to 
100,0%
> 0.5000 41,67 19,33% to 
68,05%
100,0 82,41% to 
100,0%
> 1.500 25,00 8,894% to 
53,23%
100,0 82,41% to 
100,0%
> 3.000 8,333 0,4274% to 
35,39%
100,0 82,41% to 
100,0%
Page 83 of 83
For Review Only
Sensitivity% "95% CI" Specificity% "95% CI" "Likelihood 
ratio"
"< 0.1650" 0,000 "0.000% to 
24.25%"
94,44 "74.24% to 
99.72%"
0,000
"< 0.1771" 8,333 "0.4274% to 
35.39%"
94,44 "74.24% to 
99.72%"
1,500
"< 0.2068" 8,333 "0.4274% to 
35.39%"
88,89 "67.20% to 
98.03%"
0,7500
"< 0.2315" 16,67 "2.961% to 
44.80%"
88,89 "67.20% to 
98.03%"
1,500
"< 0.2490" 16,67 "2.961% to 
44.80%"
83,33 "60.78% to 
94.16%"
1,000
"< 0.2681" 25,00 "8.894% to 
53.23%"
83,33 "60.78% to 
94.16%"
1,500
"< 0.2804" 25,00 "8.894% to 
53.23%"
77,78 "54.79% to 
91.00%"
1,125
"< 0.2915" 41,67 "19.33% to 
68.05%"
77,78 "54.79% to 
91.00%"
1,875
"< 0.3022" 50,00 "25.38% to 
74.62%"
77,78 "54.79% to 
91.00%"
2,250
"< 0.3083" 50,00 "25.38% to 
74.62%"
72,22 "49.13% to 
87.50%"
1,800
"< 0.3126" 50,00 "25.38% to 
74.62%"
66,67 "43.75% to 
83.72%"
1,500
"< 0.3186" 50,00 "25.38% to 
74.62%"
61,11 "38.62% to 
79.69%"
1,286
"< 0.3225" 50,00 "25.38% to 
74.62%"
55,56 "33.72% to 
75.44%"
1,125
"< 0.3243" 58,33 "31.95% to 
80.67%"
50,00 "29.03% to 
70.97%"
1,167
"< 0.3292" 66,67 "39.06% to 
86.19%"
50,00 "29.03% to 
70.97%"
1,333
"< 0.3509" 66,67 "39.06% to 
86.19%"
44,44 "24.56% to 
66.28%"
1,200
"< 0.3787" 75,00 "46.77% to 
91.11%"
44,44 "24.56% to 
66.28%"
1,350
"< 0.3944" 75,00 "46.77% to 
91.11%"
38,89 "20.31% to 
61.38%"
1,227
"< 0.4019" 75,00 "46.77% to 
91.11%"
33,33 "16.28% to 
56.25%"
1,125
"< 0.4065" 83,33 "55.20% to 
97.04%"
33,33 "16.28% to 
56.25%"
1,250
"< 0.4181" 83,33 "55.20% to 
97.04%"
27,78 "12.50% to 
50.87%"
1,154
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